I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Steven Thompson is someone who has spent more than two decades reshaping how clinical research actually gets done. He is the Founder of NexTrial.ai, and a leading voice at the intersection of AI, trial activation, and human centred design in healthcare.

Across roles at ADM, NuBank, Takeda, and Biogen, Steven built a reputation for transforming complex, slow, legacy processes into streamlined systems that empower the people doing the work. His philosophy is simple but radical: AI shouldn’t replace humans - it should erase the maze that holds them back.

At NexTrial.ai, he’s pioneering Trial Activation & Execution Intelligence that delivers zero rejection packets, faster startup, stronger compliance and a future where coordinators, physicians, and teams can operate at their highest capability.

Steven brings clarity, courage, and a builder’s mindset to every conversation.

*A warning, that this episode discusses important but potentially difficult topics including suicide, if you are in crisis please seek professional help.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Amelia Wrighton is the Co-Founder and CEO of the charity Suicide & Co. Her commitment to suicide bereavement is rooted in her lived experience, and is a powerful thread running through her work and leadership.

Amelia lost her mum to suicide at the age of 19, a moment that reshaped her life and set her on a path of advocacy, support and systemic change.

Instead of allowing that loss to remain silent, she chose to transform it into action, co‑founding the organisation, Suicide & Co in 2020, dedicated to helping people navigate the complex, often overlooked journey of bereavement by suicide.

She has developed services that offer counselling, guidance and a sense of community for those who suddenly find themselves in a world that doesn’t always know how to talk about traumatic grief.

The charity has been transformative in supporting my family's grief journey to recovery, since losing my darling younger sister Naomi to suicide in September 2024 and for that I will be eternally grateful.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Scott Schliebner is a seasoned biopharmaceutical executive with nearly 30 years of experience spanning biotech, CROs, and nonprofit life sciences organizations.

He currently serves as CEO and Founder of Assent Biostrategies.

Throughout his career, Scott has built and led high‑impact teams across drug development, commercial strategy, and patient‑centric innovation. His leadership includes senior roles such as Chief Commercial Officer for early‑stage biopharma service organizations and Senior Vice President at TFS HealthScience, where he oversaw clinical development services and contributed to corporate strategy and acquisition due diligence.

Scott is widely recognized as a patient advocate and strategic thinker who helps biotech companies accelerate their pipelines and design development programs that meaningfully incorporate patient needs.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Helene Quie is a strategic decision‑maker, founder and CEO of Qmed Consulting, a global healthcare consultancy CRO driving medical device innovation.

With more than 25 years at the intersection of science, regulation, and commercial strategy, Helene advises start‑ups and established medtech firms, helping leadership teams translate breakthrough ideas into market‑ready products.

Her career includes senior operational roles across leading medtech organisations.

In 2006 she founded Qmed to bridge innovation and regulation while elevating patient safety and commercial success.

Today Qmed supports medtech pioneers across Europe and beyond, guiding clinical investigations, regulatory transitions, evidence generation and organisational transformation.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Sylvain Berthelot is a clinical technology and life sciences professional with deep expertise in clinical systems and the digital ecosystem that supports modern clinical research. Having worked extensively with sponsors, CROs, and clinical teams, he understands how technology can either streamline or complicate the delivery of high‑quality, compliant clinical trials.

In 2024, he joined CRScube, a company whose mission aligns with his commitment to simplifying clinical trial execution through intuitive, people‑centred technology.

Alongside his work in clinical innovation, Sylvain is an active voice in industry and patient‑centric conversations through podcasting. He hosts Clinical Data Talks, a podcast that explores the challenges, innovations, and real‑world experiences shaping clinical data management and clinical operations.

Sylvain also hosts On One Condition, a human‑focused podcast that raises awareness about chronic health conditions by sharing personal stories.

Combining technical expertise with a strong human perspective, Sylvain is dedicated to bridging the gap between systems, data, and the people they ultimately serve.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Today we’re joined by Dr.Thibault Geoui - host of the acclaimed Tech and Drugs podcast and a driving force at the intersection of biotech innovation and digital transformation.

His podcast has become a go-to platform for unpacking the future of pharma, where Thibault brings a rare blend of scientific insight and startup savvy, having worked across R&D, venture strategy, and digital health ecosystems.

As Head of Science Analytics at Charles River Laboratories, Dr. Géoui spearheaded the creation of a forward-thinking product and data strategy — leveraging advanced digital solutions to accelerate discovery and keep the organization at the leading edge of the life sciences sector.

In his current role as Director of Transformation at Zühlke, he leads the go-to-market strategy for the company’s Pharma Lab Automation offering, aligning engineering excellence with the real-world demands of drug R&D.

His work includes translating complex science into actionable insight, and for connecting the dots between technology, regulation, and patient impact.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Jura Lasas is a clinical research leader and biotech consultant specializing in rare disease clinical operations for small biopharma and biotech companies.

With over 20 years bridging academia and industry, she's become the operational compass for biotechs navigating their early phase clinical trials.

Her journey began more than 2 decades ago in a newly independent Lithuania, where she stood at an airport with $400 in her pocket and a one-way ticket to America.

That calculated risk, leaving everything known for everything possible, became the template for her career: courage mixed with ruthless pragmatism.

She holds a PhD in Neurobiology, which shapes how she approaches both science and leadership.

Her career spans both CRO and sponsor side leadership, and she has lived and worked across three continents.

That global experience gives her a strong understanding of cultural differences in medicine, research, communication, and decision making.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Today, I’m joined by Sam Usher.

His career began by accident. A place at the National Youth Theatre sparked a fascination with performance that quickly evolved into choreography — the power of expression through the body, communicating emotion without words. He trained at Ballet Rambert and at the Northern School of Contemporary Dance in Leeds before moving to Brussels to perform while simultaneously creating his own work through his company, Feed.

After twelve years in dance, a planned move to Montreal took an unexpected detour to Devon for the summer — where he picked up a camera and never put it down. Film replaced the stage, leading to his first ITV commission: a ski series focused not on spectacle, but on the individuals and preparation behind elite performance. That project took him to Chamonix and marked the start of a new direction.

From mountain couloirs to open water, sailing introduced him to live sport — the closest thing to stage adrenaline. He built a successful production company that ran for fifteen years before the disruption of lockdown forced another reinvention.

Chapter three is rooted in wellbeing: Steam Works — a community-led sauna experience designed around connection, ritual and reset, where Sam and I first met on the beach in South Devon, Bigbury-on-sea.